Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis

Pulmonary Medicine

Volumn , Issue , 2011, Pages

  Tzouvelekis, Argyris ^a   Bouros, Evangelos ^b   Oikonomou, Anastasia ^a   Ntolios, Paschalis ^b   Zacharis, George ^a   Kolios, George ^b   Bouros, Demosthenes ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); DRUG EFFECT; DRUG SAFETY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84876509259     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2011/849035     Document Type: Article

References (33)

1. American Thoracic Society, Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American thoracic society (ATS), and the European respiratory society (ERS) American Journal of Respiratory and Critical Care Medicine 2000 161 2, part 1 646 664
2. Selman M., Pardo A., Idiopathic pulmonary fibrosis: misunderstandings between epithelial cells and fibroblasts? Sarcoidosis Vasculitis and Diffuse Lung Diseases 2004 21 3 165 172 (Pubitemid 39472239)
3. Selman M., Pardo A., Kaminski N., Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? Plos Medicine 2008 5 3, article e62
4. Tzouvelekis A., Kouliatsis G., Anevlavis S., Bouros D., Serum biomarkers in interstitial lung diseases Respiratory Research 2005 6, article 78
5. Tzouvelekis A., Harokopos V., Paparountas T., Oikonomou N., Chatziioannou A., Vilaras G., Tsiambas E., Karameris A., Bouros D., Aidinis V., Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1 in disease pathogenesis American Journal of Respiratory and Critical Care Medicine 2007 176 11 1108 1119 (Pubitemid 350223757)
6. Oikonomou N., Thanasopoulou A., Tzouvelekis A., Harokopos V., Paparountas T., Nikitopoulou I., Witke W., Karameris A., Kotanidou A., Bouros D., Aidinis V., Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis Thorax 2009 64 6 467 475
7. Anstrom K. J., Kaner R. J., Loyd J. E., Roman J., The IPFnet strategy: creating a comprehensive approach in the treatment of idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2010 181 6 527 528
8. Bouros D., Antoniou K. M., Current and future therapeutic approaches in idiopathic pulmonary fibrosis European Respiratory Journal 2005 26 4 693 702 (Pubitemid 41448670)
9. Raghu G., Improving the standard of care for patients with idiopathic pulmonary fibrosis requires participation in clinical trials Chest 2009 136 2 330 333
10. Allison A. C., Eugui E. M., Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection Transplantation 2005 80 supplement 2 S181 S190
11. Allison A. C., Mechanisms of action of mycophenolate mofetil Lupus 2005 14 1 s2 s8
12. Ciancio G., Burke G. W., Gaynor J. J., Mattiazzi A., Roth D., Kupin W., Nicolas M., Ruiz P., Rosen A., Miller J., A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (neoral)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year Transplantation 2004 77 supplement 2 252 258 (Pubitemid 38155755)
13. Ciancio G., Burke G. W., Gaynor J. J., Mattiazzi A., Roth D., Kupin W., Nicolas M., Ruiz P., Rosen A., Miller J., A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (neoral) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year Transplantation 2004 77 2 244 251 (Pubitemid 38155754)
14. Ciancio G., Miller J., Gonwa T. A., Review of major clinical trial with mycophenolate mofetil in renal transplantation Transplantation 2005 80 supplement 2 S191 S200
15. Appel G. B., Radhakrishnan J., Ginzler E. M., Use of mycophenolate mofetil in autoimmune and renal diseases Transplantation 2005 80 supplement 2 S265 S271
16. Waller J. R., Brook N. R., Bicknell G. R., Murphy G. J., Nicholson M. L., Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration Transplantation Proceedings 2005 37 1 164 166 (Pubitemid 40459724)
17. Goh N. S., Desai S. R., Veeraraghavan S., Hansell D. M., Copley S. J., Maher T. M., Corte T. J., Sander C. R., Ratoff J., Devaraj A., Bozovic G., Denton C. P., Black C. M., Du Bois R. M., Wells A. U., Interstitial lung disease in systemic sclerosis: a simple staging system American Journal of Respiratory and Critical Care Medicine 2008 177 11 1248 1254 (Pubitemid 351860934)
18. Austin J. H. M., Muller N. L., Friedman P. J., Hansell D. M., Naidich D. P., Remy-Jardin M., Webb W. R., Zerhouni E. A., Glossary of terms for CT of the lungs: recommendations of the nomenclature committee of the fleischner society Radiology 1996 200 2 327 331 (Pubitemid 26249879)
19. Antoniou K. M., Nicholson A. G., Dimadi M., Malagari K., Latsi P., Rapti A., Tzanakis N., Trigidou R., Polychronopoulos V., Bouros D., Long-term clinical effects of interferon -1b and colchicine in idiopathic pulmonary fibrosis European Respiratory Journal 2006 28 3 496 504 (Pubitemid 44794663)
20. Bouros D., Interferon for idiopathic pulmonary fibrosis The Lancet 2009 374 9685 180 182
21. Demedts M., Behr J., Buhl R., Costabel U., Dekhuijzen R., Jansen H. M., MacNee W., Thomeer M., Wallaert B., Laurent F., Nicholson A. G., Verbeken E. K., Verschakelen J., Flower C. D. R., Capron F., Petruzzelli S., De Vuyst P., Van Den Bosch J. M. M., Rodriguez-Becerra E., Corvasce G., Lankhorst I., Sardina M., Montanari M., High-dose acetylcysteine in idiopathic pulmonary fibrosis The New England Journal of Medicine 2005 353 21 2229 2242 (Pubitemid 41697286)
22. King T. E. Jr., Behr J., Brown K. K., Du Bois R. M., Lancaster L., De Andrade J. A., Sthler G., Leconte I., Roux S., Raghu G., BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2008 177 1 75 81
23. King T. E. Jr., Albera C., Bradford W. Z., Costabel U., Hormel P., Lancaster L., Noble P. W., Sahn S. A., Szwarcberg J., Thomeer M., Valeyre D., du Bois R. M., Effect of interferon -1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial The Lancet 2009 374 9685 222 228
24. Raghu G., Brown K. K., Costabel U., Cottin V., Du Bois R. M., Lasky J. A., Thomeer M., Utz J. P., Khandker R. K., McDermott L., Fatenejad S., Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial American Journal of Respiratory and Critical Care Medicine 2008 178 9 948 955
25. Zisman D. A., Schwarz M., Anstrom K. J., Collard H. R., Flaherty K. R., Hunninghake G. W., A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis The New England Journal of Medicine 2010 363 7 620 628
26. Allison A. C., Eugui E. M., Mycophenolate mofetil and its mechanisms of action Immunopharmacology 2000 47 2-3 85 118 (Pubitemid 30394534)
27. Liossis S. N., Bounas A., Andonopoulos A. P., Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease Rheumatology 2006 45 8 1005 1008 (Pubitemid 44283057)
28. Gerbino A. J., Goss C. H., Molitor J. A., Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease Chest 2008 133 2 455 460 (Pubitemid 351272405)
29. Koutroumpas A., Ziogas A., Alexiou I., Barouta G., Sakkas L. I., Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease Clinical Rheumatology 2010 29 10 1167 1168
30. Feghali-Bostwick C. A., Tsai C. G., Valentine V. G., Kantrow S., Stoner M. W., Pilewski J. M., Gadgil A., George M. P., Gibson K. F., Choi A. M. K., Kaminski N., Zhang Y., Duncan S. R., Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis Journal of Immunology 2007 179 4 2592 2599
31. Kotsianidis I., Nakou E., Bouchliou I., Tzouvelekis A., Spanoudakis E., Steiropoulos P., Sotiriou I., Aidinis V., Margaritis D., Tsatalas C., Bouros D., Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2009 179 12 1121 1130
32. Luzina I. G., Todd N. W., Iacono A. T., Atamas S. P., Roles of T lymphocytes in pulmonary fibrosis Journal of Leukocyte Biology 2008 83 2 237 244 (Pubitemid 351225603)
33. Altschuler E. L., Consideration of mycophenolate mofetil for idiopathic pulmonary fibrosis Medical Hypotheses 2001 57 6 701 702 (Pubitemid 34014367)